Dyno Therapeutics Signs US$1.8 B Gene Therapy Pact with Roche

By Pratika Pahwa & Michelle Liu

Pharma Deals Review: Vol 2020 Issue 10 (Table of Contents)

Published: 30 Oct-2020

DOI: 10.3833/pdr.v2020.i10.2566     ISSN: 1756-7874

Section: Licensing



In its third deal since it emerged from stealth in May 2020, Dyno Therapeutics has entered into a collaboration and license agreement with Roche to develop adeno-associated virus vectors for gene therapies for central nervous system diseases and liver-directed therapies...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details